PD 163070, a potent endothelin-A selective antagonist with long duration of action.

被引：0

作者：

Lee, C ^{[1
]}

Cheng, XM ^{[1
]}

Repine, J ^{[1
]}

Bradford, L ^{[1
]}

Reyner, E ^{[1
]}

Stewart, B ^{[1
]}

Hallak, H ^{[1
]}

Welch, KM ^{[1
]}

Walker, D ^{[1
]}

Haleen, S ^{[1
]}

Doherty, A ^{[1
]}

机构：

[1] WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES DIV,ANN ARBOR,MI 48105

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1997年 / 213卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：195 / MEDI

页数：1

共 50 条

[21] Role of ambrisentan (selective endothelin-A receptor antagonist) on cigarette smoke exposure induced cognitive impairment in Danio rerio
Muthuraman, Arunachalam
Nafisa, Kamus
Sowmya, Mysore Srinivasmurthy
Arpitha, Bachahalli Madappa
Choedon, Nagdol
Sandy, Crasta Denis
Rishitha, Narahari
Johurul, Islam
LIFE SCIENCES, 2019, 222 : 133 - 139
[22] Hypotension associated with systemic aggregated anaphylaxis is not attenuated by a selective endothelin-A receptor antagonist, BQ 610, in rabbits in vivo
Takayuki Kawakami
Hiromasa Mitsuhata
Jin Saitoh
Haruhiko Takeuchi
Naoki Hasome
Masahiro Hiruta
Yukari Horikawa
Norimasa Seo
Journal of Anesthesia, 2003, 17 (1) : 22 - 29
[23] POTENT AND SELECTIVE ENDOTHELIN-A RECEPTOR ANTAGONISTS BASED ON PHENYLACETATE-TERMINATED OXAZOLE-4-CARBOXYLIC ACIDS
SORENSEN, BK
TASKER, AS
BAL, RB
VONGELDERN, TW
DIXON, D
CALZADILLA, S
DAYTON, BB
WUWONG, JR
OPGENORTH, TJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 33 - MEDI
[24] Administration of a selective endothelin-A receptor antagonist (BSF 208075) improves hepatic warm ischemia/reperfusion injury in pigs
Witzigmann, H
Ludwig, S
Escher, E
Armann, B
Gäbel, G
Teupser, D
Tannapfel, A
Pietsch, UC
Hauss, J
Uhlmann, D
TRANSPLANTATION PROCEEDINGS, 2002, 34 (06) : 2387 - 2388
[25] TBC3711 is a potent, orally available, and ETA selective endothelin antagonist.
Wu, CD
Decker, ER
Blok, N
Bui, H
Knowles, V
Bourgoyne, A
Holland, GW
Brock, TA
Dixon, RAF
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A108 - A109
[26] CHARACTERIZATION OF A POTENT AND SELECTIVE ENDOTHELIN-B RECEPTOR ANTAGONIST, IRL-2500
BALWIERCZAK, JL
BRUSEO, CW
DELGRANDE, D
JENG, AY
SAVAGE, P
SHETTY, SS
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 : S393 - S396
[27] Characterization of the potent endothelin(A/B)-antagonist PD cerebral vessels combined 142893 on cerebral vessels
Zimmermann, M
Vatter, H
Weyrauch, E
Lange, BN
Krishnan, R
Raabe, A
Seifert, V
NEUROLOGICAL RESEARCH, 2004, 26 (06) : 692 - 697
[28] Evaluation of the effect of endothelin-1 and characterization of the selective endothelin A receptor antagonist PD155080 in the prostate
Imajo, C
Walden, PD
Shapiro, E
Doherty, AM
Lepor, H
JOURNAL OF UROLOGY, 1997, 158 (01): : 253 - 257
[29] PD 180988, a potent ETA selective antagonist and its therapeutic potential.
Cheng, XM
Lee, C
Repine, JT
Skeean, RS
Berryman, KA
Bunker, AM
Edmunds, JJ
Doherty, AM
Haleen, SJ
Shroeder, R
Walker, DM
Welch, KM
Hallak, H
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1195 - U1195
[30] Association of a selective endothelin-A receptor antagonist (ET-A RA) could improve the outcome of patients with hepatorenal syndrome (HRS)
Popescu, A
Voiculescu, M
JOURNAL OF HEPATOLOGY, 2004, 40 : 71 - 72

← 1 2 3 4 5 →